Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Clinical Trials

Cardiovascular Research

Think of all of the medical advances we enjoy today that our parents and grandparents probably never dreamed possible—open-heart surgery to open blocked arteries, pacemakers and implantable defibrillators to control irregular heartbeats, even cholesterol-lowering medications. The research advantages we benefit from today are all possible because people before us were willing to test them as volunteers in medical research studies.

The Center for Heart & Vascular Health is actively involved in dozens of current research studies that are advancing the science of cardiovascular care. At any given time, these studies might include new treatments for heart attacks, congestive heart failure, blocked arteries, irregular heartbeats and high cholesterol. Studies include new techniques in cardiac catheterization and open-heart surgery, arrhythmia management, new therapies to reduce the damaging effects of heart disease, and the search for new ways to reduce pain and promote healing for heart patients.

In many nationwide studies, ChristianaCare has been a recognized leader, both in enrolling significant numbers of study participants and in having research results published by our own cardiovascular physicians in world-renowned medical journals.

You can help to shape the future of cardiovascular care

Ask your doctor if there is a clinical trial that might hold the key for a better treatment for your cardiac condition. Not only could it help improve your own health; your participation could help shape the future of cardiovascular care for generations to come. To learn more, or to find out if you qualify for a cardiovascular research trial, call 302-733-2658.